glp-1 sandy medications are changing lives—but what happens to the face during rapid weight loss? In this episode, and Marlo unpack the science behind “Ozempic face,” what clinicians are seeing in GLP-1 Drugs Could Raise the

Growing evidence suggests that GLP-1 receptor agonists like semaglutide may offer unexpected benefits beyond weight loss, including potential migraine relief through metabolic and inflammatory pathways

#BoletnDeprensa El Invima informa sobre la comercializacin ilegal de los parches GLP-1 PATCHES (LUMESSA), promocionados en internet como mtodo para bajar de peso sin registro sanitario en Colombia.

Then came the duals (like #tirzepatide), and even triagonists (#retatrutide) that pushed weight loss even farther

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated cardiovascular and kidney benefits in the general population with type 2 diabetes mellitus (T2DM), evidence regarding their effects in diabetic KTRs is limited

Mean TTR decreased by 2.1% (95% CI, -3.7% to -0.6%

Together, they create a synergistic blend to support bowel regularity and overall gut health